Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$1.2 - $2.73 $1.63 Million - $3.7 Million
-1,356,887 Reduced 85.55%
229,226 $309,000
Q4 2022

Feb 14, 2023

BUY
$1.71 - $3.61 $1.18 Million - $2.49 Million
690,816 Added 77.16%
1,586,113 $2.95 Million
Q3 2022

Nov 14, 2022

BUY
$1.9 - $8.63 $102,083 - $463,672
53,728 Added 6.38%
895,297 $2.2 Million
Q2 2022

Aug 15, 2022

SELL
$2.13 - $9.01 $880,919 - $3.73 Million
-413,577 Reduced 32.95%
841,569 $2.05 Million
Q1 2022

May 16, 2022

SELL
$6.28 - $15.59 $86,010 - $213,520
-13,696 Reduced 1.08%
1,255,146 $9.99 Million
Q4 2021

Feb 14, 2022

SELL
$14.7 - $28.67 $2.17 Million - $4.23 Million
-147,519 Reduced 10.42%
1,268,842 $19.6 Million
Q3 2021

Nov 12, 2021

SELL
$24.31 - $33.6 $625,399 - $864,393
-25,726 Reduced 1.78%
1,416,361 $44.7 Million
Q2 2021

Aug 16, 2021

BUY
$26.09 - $40.4 $13.3 Million - $20.6 Million
509,087 Added 54.56%
1,442,087 $48.6 Million
Q1 2021

May 17, 2021

BUY
$33.06 - $56.93 $2.41 Million - $4.15 Million
72,879 Added 8.47%
933,000 $35.7 Million
Q4 2020

May 17, 2021

BUY
$39.09 - $57.4 $1.55 Million - $2.28 Million
39,645 Added 4.83%
860,121 $36 Million
Q4 2020

Feb 16, 2021

BUY
$39.09 - $57.4 $2.09 Million - $3.06 Million
53,374 Added 6.96%
820,476 $34.3 Million
Q3 2020

Nov 16, 2020

BUY
$28.43 - $44.67 $1.2 Million - $1.89 Million
42,259 Added 5.83%
767,102 $33.3 Million
Q2 2020

Aug 14, 2020

BUY
$11.71 - $30.29 $1.2 Million - $3.1 Million
102,309 Added 16.43%
724,843 $22 Million
Q1 2020

May 14, 2020

BUY
$7.64 - $27.5 $1.03 Million - $3.72 Million
135,318 Added 27.77%
622,534 $8.51 Million
Q4 2019

Feb 14, 2020

BUY
$15.02 - $20.57 $107,798 - $147,630
7,177 Added 1.5%
487,216 $7.86 Million
Q3 2019

Nov 14, 2019

SELL
$18.85 - $27.5 $10.1 Million - $14.8 Million
-537,034 Reduced 52.8%
480,039 $9.25 Million
Q2 2019

Aug 15, 2019

BUY
$17.37 - $26.27 $17.7 Million - $26.7 Million
1,017,073 New
1,017,073 $23.9 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.